Baxter International (BAX) Revenue — Quarter Ended Mar 31, 2024
Revenue for the quarter declined from the immediately preceding quarter but rose compared with the same quarter one year earlier. The sequential decrease contrasts with the year-over-year gain, reflecting a mixed quarterly performance.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue for the quarter declined from the immediately preceding quarter but rose compared with the same quarter one year earlier. The sequential decrease contrasts with the year-over-year gain, reflecting a mixed quarterly performance.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.5B
Revenue reported for this quarter.
Quarter-over-quarter
-8.8%
Change from the immediately preceding quarter.
Year-over-year
+2.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$10.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $4.8B | +33.0% |
| Sep 30, 2023 | $414M | -88.5% |
| Dec 31, 2023 | $2.7B | -27.1% |
| Mar 31, 2024 | $2.5B | +2.0% |
Revenue performance
Revenue was lower than the prior quarter, while it was higher than the same period a year ago. The quarter's result continued the volatility seen in recent periods.
Quarterly comparison
Compared with the immediately preceding quarter, revenue decreased. However, compared with the same quarter one year earlier, revenue increased.
What to watch
The company continued to incur costs related to the separation of its Kidney Care business, which affected operating cash flows during the quarter.